TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/10/2024
Back to search
Official data from USPTO
PREDNISTAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/10/2024
Trademark type
Word
Nice classes
5
Filing date
09/18/1991
Registration date
07/21/1992
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2022
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
04/12/1991
First use in commerce
04/12/1991
Drawing code
1
Owner type
03
Owner location
Shenandoah, IA
Examiner
BUCHANAN WILL, NORA
Law office
G30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
LLOYD, INC. OF IOWA
VET-A-MIX, INC.
Representatives
Mari-Elise Paul McBrayer PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
synthetic dehydrogenated analogue of cortisone for veterinary use in the treatment of inflammatorydermatologicalmusculo-skeletal and arthritic conditions
Publications
History of USPTO decisions and trademark events.
28 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/10/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/15/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/15/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/06/2022
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
01/06/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/06/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
07/27/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/21/2021
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
09/29/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/29/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
09/27/2011
CFIT
CASE FILE IN TICRS
01/30/2008
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/10/2002
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/10/2002
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
05/07/2002
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/09/1997
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
09/17/1997
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/1992
PUBO
PUBLISHED FOR OPPOSITION
04/28/1992
NPUB
NOTICE OF PUBLICATION
03/27/1992
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/1992
CNEA
EXAMINER'S AMENDMENT MAILED
12/16/1991
DOCK
ASSIGNED TO EXAMINER
12/12/1991
Continuous trademark protection
Get notified about every new filing that threatens PREDNISTAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.